PRF1 and neoplasm: CAR-T cells are autologous isolated T cells, genetically engineered through the use of antibody fragments to carry a receptor capable of recognizing specific antigens expressed by tumor cells, being reinfused to patients to stimulate cancer immune surveillance through secretion of perforin and granzyme granules and activation of programmed cell death.